Back to top
more

Adient (ADNT)

(Delayed Data from NYSE)

$21.40 USD

21.40
1,493,821

-0.04 (-0.19%)

Updated Aug 1, 2025 03:59 PM ET

After-Market: $21.40 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (89 out of 246)

Industry: Automotive - Original Equipment

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Is Adient (ADNT) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Here's Why Adient (ADNT) is a Strong Momentum Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Implied Volatility Surging for Adient (ADNT) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Adient (ADNT) stock based on the movements in the options market lately.

Zacks Equity Research

Adient (ADNT) Down 12.2% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

What Makes Adient (ADNT) a New Buy Stock

by Zacks Equity Research

Adient (ADNT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Is Adient (ADNT) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Adient (ADNT) Q3 Earnings & Sales Beat, Guidance Lifted

by Zacks Equity Research

Adient (ADNT) envisions fiscal 2023 revenues and adjusted EBITDA of $15.4 billion and $920 million, up from the prior guidance of $15 billion and $850 million, respectively.

Zacks Equity Research

Adient (ADNT) Reports Q3 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

While the top- and bottom-line numbers for Adient (ADNT) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Adient (ADNT) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Adient (ADNT) delivered earnings and revenue surprises of 151.28% and 6.55%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Commercial Vehicle Group (CVGI) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Commercial Vehicle Group (CVGI) delivered earnings and revenue surprises of 28% and 0.43%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Adient (ADNT) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Adient (ADNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Why Adient (ADNT) is a Top Momentum Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

New Strong Sell Stocks for June 13th

by Zacks Equity Research

ADNY, BHKLY and EQH have been added to the Zacks Rank #5 (Strong Sell) List on June 13, 2023.

Zacks Equity Research

Adient (ADNT) Up 0.5% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Adient (ADNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Adient (ADNT) Q2 Earnings Miss Estimates, Revenues Rise Y/Y

by Zacks Equity Research

Adient's (ADNT) second-quarter 2023 earnings lag estimates owing to weaker-than-expected EBITDA from the Americas segment.

Zacks Equity Research

Here's What Key Metrics Tell Us About Adient (ADNT) Q2 Earnings

by Zacks Equity Research

The headline numbers for Adient (ADNT) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Equity Research

Adient (ADNT) Lags Q2 Earnings Estimates

by Zacks Equity Research

Adient (ADNT) delivered earnings and revenue surprises of -21.95% and 5.24%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Is a Surprise Coming for Adient (ADNT) This Earnings Season?

by Zacks Equity Research

Adient (ADNT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Equity Research

BorgWarner (BWA) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

BorgWarner (BWA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Adient (ADNT) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Adient (ADNT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Adient (ADNT) Q1 Earnings Miss on Poor EMEA Unit Results

by Zacks Equity Research

Adient's (ADNT) fiscal Q1 earnings lag estimates owing to weaker-than-expected revenues and EBITDA from the EMEA unit.

Zacks Equity Research

Adient (ADNT) Q1 Earnings and Revenues Lag Estimates

by Zacks Equity Research

Adient (ADNT) delivered earnings and revenue surprises of -15% and 0.53%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

A Peek Into Key Predictions Ahead of Cummins (CMI) Q4 Earnings

by Zacks Equity Research

The Zacks Consensus Estimate for Cummins' (CMI) Q4 earnings per share and revenues is pegged at $4.66 and $7.36 billion, respectively.

Zacks Equity Research

Can Penske (PAG) Please Investors This Earnings Season?

by Zacks Equity Research

The Zacks Consensus Estimate for Penske's (PAG) Q4 earnings per share and revenues is pegged at $4.03 and $6.38 billion, respectively.

Zacks Equity Research

Earnings Preview: BorgWarner (BWA) Q4 Earnings Expected to Decline

by Zacks Equity Research

BorgWarner (BWA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.